Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Zhi-Gang She and Haomiao Li.
Zhi-Gang She
Connection Strength
0.566
Haomiao Li
  1. No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19. World J Clin Cases. 2020 Nov 26; 8(22):5576-5588.
    View in: PubMed
    Score: 0.229
  2. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. Cell Metab. 2021 02 02; 33(2):258-269.e3.
    View in: PubMed
    Score: 0.058
  3. Kidney Function Indicators Predict Adverse Outcomes of COVID-19. Med (N Y). 2021 Jan 15; 2(1):38-48.e2.
    View in: PubMed
    Score: 0.057
  4. Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 10 06; 32(4):537-547.e3.
    View in: PubMed
    Score: 0.056
  5. Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China. Hepatology. 2020 08; 72(2):389-398.
    View in: PubMed
    Score: 0.056
  6. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 08; 76(2):e15-e17.
    View in: PubMed
    Score: 0.055
  7. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 06 02; 31(6):1068-1077.e3.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.